Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
OKYO Pharma Limited Sponsored ADR (OKYO) had Return on Tangible Equity of 84.80% for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.71M |
|
-- |
|
-- |
|
$7.09M |
|
$-7.09M |
|
$-0.88M |
|
$-7.97M |
|
$-7.97M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-4.71M |
|
$-7.09M |
|
$-7.09M |
|
39.49M |
|
39.49M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$3.68M |
|
$0.00M |
|
$0.00M |
|
$3.68M |
|
$9.23M |
|
-- |
|
-- |
|
$9.23M |
|
$-5.55M |
|
$-5.55M |
|
$-5.55M |
|
36.02M |
|
| Cash Flow Statement Financials | |
$-1.81M |
|
$-0.00M |
|
$2.66M |
|
$0.83M |
|
$1.56M |
|
$0.73M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
84.80% |
|
|
Return on Tangible Equity |
84.80% |
-127.98% |
|
84.80% |
|
$-0.15 |
|
$-0.05 |
|
$-0.05 |
|